![Lei Chen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lei Chen
Direktor/Vorstandsmitglied bei SHANGHAI XFH TECHNOLOGY CO., LTD
Aktive Positionen von Lei Chen
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SHANGHAI XFH TECHNOLOGY CO., LTD | Direktor/Vorstandsmitglied | 20.01.2016 | - |
Beijing Shenogen Pharma Group Ltd.
![]() Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Lei Chen
Ausbildung von Lei Chen
Tsinghua University | Graduate Degree |
Statistik
International
China | 4 |
Operativ
Director/Board Member | 2 |
Graduate Degree | 1 |
Sektoral
Producer Manufacturing | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SHANGHAI XFH TECHNOLOGY CO., LTD | Producer Manufacturing |
Private Unternehmen | 1 |
---|---|
Beijing Shenogen Pharma Group Ltd.
![]() Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |